| Myocardial Infarction (MI) |
1 |
1 |
| Type 2 Diabetes Mellitus |
0 |
0.9 |
| Heart Failure (HF) |
0 |
0.74 |
| Heart |
0 |
0.66 |
| SGLT2 Inhibitor |
0 |
0.99 |
| Chronic Kidney Disease |
0 |
0.27 |
| Renal Failure |
0 |
0.27 |
| Renal Disease |
0 |
0.23 |
| Clinical Guidelines |
0 |
0.22 |
| Hospital |
0 |
0.22 |
| Kidney |
0 |
0.22 |
| Acute Coronary Syndrome |
0 |
0.18 |
| Acute Myocardial Infarction (MI) |
0 |
0.16 |
| Board Certification |
0 |
0.11 |
| Clinical Research |
0 |
0.11 |
| Europe |
0 |
0.11 |
| Infarction |
0 |
0.11 |
| Ischemia |
0 |
0.11 |
| New York |
0 |
0.11 |
| UK Site Content |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.1 |